Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

D-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence.

Santa Ana EJ, Prisciandaro JJ, Saladin ME, McRae-Clark AL, Shaftman SR, Nietert PJ, Brady KT.

Am J Addict. 2015 Apr;24(3):217-24. doi: 10.1111/ajad.12191. Epub 2015 Mar 24.

2.

Raynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort.

Nietert PJ, Shaftman SR, Silver RM, Wolf BJ, Egan BM, Hunt KJ, Smith EA.

Clin Epidemiol. 2015 Feb 3;7:161-8. doi: 10.2147/CLEP.S75482. eCollection 2015.

3.

Outcome of patients with negative and unsatisfactory cytologic specimens obtained by endobronchial ultrasound-guided transbronchial fine-needle aspiration of mediastinal lymph nodes.

Mehta HJ, Tanner NT, Silvestri G, Simkovich SM, Shamblin C, Shaftman SR, Nietert PJ, Yang J.

Cancer Cytopathol. 2015 Feb;123(2):92-7. doi: 10.1002/cncy.21482. Epub 2014 Sep 3.

4.

Genes associated with SLE are targets of recent positive selection.

Ramos PS, Shaftman SR, Ward RC, Langefeld CD.

Autoimmune Dis. 2014;2014:203435. doi: 10.1155/2014/203435. Epub 2014 Jan 23. Review.

5.

NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis.

Oates JC, Mashmoushi AK, Shaftman SR, Gilkeson GS.

Lupus. 2013 Nov;22(13):1361-70. doi: 10.1177/0961203313507988. Epub 2013 Oct 8.

6.

Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence.

Barth KS, Maria MM, Lawson K, Shaftman S, Brady KT, Back SE.

Am J Addict. 2013 Sep-Oct;22(5):486-91. doi: 10.1111/j.1521-0391.2013.12038.x. Epub 2013 May 15.

7.

The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules.

Mehta HJ, Ravenel JG, Shaftman SR, Tanner NT, Paoletti L, Taylor KK, Tammemagi MC, Gomez M, Nietert PJ, Gould MK, Silvestri GA.

Chest. 2014 Mar 1;145(3):464-472. doi: 10.1378/chest.13-0708.

8.

Association of elevated cytokines with childhood adversity in a sample of healthy adults.

Hartwell KJ, Moran-Santa Maria MM, Twal WO, Shaftman S, DeSantis SM, McRae-Clark AL, Brady KT.

J Psychiatr Res. 2013 May;47(5):604-10. doi: 10.1016/j.jpsychires.2013.01.008. Epub 2013 Feb 14.

9.

E4D compare software: an alternative to faculty grading in dental education.

Renne WG, McGill ST, Mennito AS, Wolf BJ, Marlow NM, Shaftman S, Holmes JR.

J Dent Educ. 2013 Feb;77(2):168-75.

10.

Comparing the symptoms of posttraumatic stress disorder with the distress and fear disorders.

Gros DF, Magruder KM, Ruggiero KJ, Shaftman SR, Frueh BC.

J Nerv Ment Dis. 2012 Nov;200(11):967-72. doi: 10.1097/NMD.0b013e3182718a36.

PMID:
23124181
11.

The health education for lupus study: a randomized controlled cognitive-behavioral intervention targeting psychosocial adjustment and quality of life in adolescent females with systemic lupus erythematosus.

Brown RT, Shaftman SR, Tilley BC, Anthony KK, Kral MC, Maxson B, Mee L, Bonner MJ, Vogler LB, Schanberg LE, Connelly MA, Wagner JL, Silver RM, Nietert PJ.

Am J Med Sci. 2012 Oct;344(4):274-82.

12.

Demographic differences in the treatment and control of glucose in type 2 diabetic patients: implications for health care practice.

Egan BM, Shaftman SR, Wagner CS, Bandyopadhyay D, Szymanski KA.

Ethn Dis. 2012 Winter;22(1):29-37.

PMID:
22774306
13.

Initial monotherapy and combination therapy and hypertension control the first year.

Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS.

Hypertension. 2012 Jun;59(6):1124-31. doi: 10.1161/HYPERTENSIONAHA.112.194167. Epub 2012 May 7.

14.

Motives for using: a comparison of prescription opioid, marijuana and cocaine dependent individuals.

Hartwell KJ, Back SE, McRae-Clark AL, Shaftman SR, Brady KT.

Addict Behav. 2012 Apr;37(4):373-8. doi: 10.1016/j.addbeh.2011.11.014. Epub 2011 Nov 23.

15.

Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients.

Ravenell RL, Kamen DL, Spence JD, Hollis BW, Fleury TJ, Janech MG, Almeida JS, Shaftman SR, Oates JC.

Am J Med Sci. 2012 Oct;344(4):268-73.

16.

The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension.

Pavy-Le Traon A, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Shaftman SR, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Stebbins GT, Rascol O.

Mov Disord. 2011 Sep;26(11):1985-92. doi: 10.1002/mds.23742. Epub 2011 May 5. Review.

PMID:
21547951
17.

Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.

Elble RJ, Suchowersky O, Shaftman S, Weiner WJ, Huang P, Tilley B; NINDS NET-PD Investigators.

Mov Disord. 2010 Jun 15;25(8):1082-6. doi: 10.1002/mds.22997.

18.

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N; Movement Disorder Society UPDRS Revision Task Force.

Mov Disord. 2008 Nov 15;23(15):2129-70. doi: 10.1002/mds.22340.

PMID:
19025984
19.

Autoantibody prevalence and lupus characteristics in a unique African American population.

Kamen DL, Barron M, Parker TM, Shaftman SR, Bruner GR, Aberle T, James JA, Scofield RH, Harley JB, Gilkeson GS.

Arthritis Rheum. 2008 May;58(5):1237-47. doi: 10.1002/art.23416.

20.

Supplemental Content

Loading ...
Support Center